Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06263088
Title field or adapter rule
{'original_value': 'EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:25.763361+00:00
Published At
2026-09-15T00:00:00+00:00
Record Updated At
2026-09-15
Source Retrieved At
2026-10-31T22:17:56.788771+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Gastrointestinal Cancer", "Colon Cancer", "Rectal Cancer", "Anal Cancer", "Esophageal Cancer", "Stomach Cancer", "Appendix Cancer", "Pancreas Cancer", "Liver Cancer", "Neuroendocrine Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-09-15", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT06263088"
protocolSection.identificationModule.officialTitle
"EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer."
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Gastrointestinal Cancer (protocolSection.conditionsModule.conditions)
  • Colon Cancer (protocolSection.conditionsModule.conditions)
  • Rectal Cancer (protocolSection.conditionsModule.conditions)
  • Anal Cancer (protocolSection.conditionsModule.conditions)
  • Esophageal Cancer (protocolSection.conditionsModule.conditions)
  • Stomach Cancer (protocolSection.conditionsModule.conditions)
  • Appendix Cancer (protocolSection.conditionsModule.conditions)
  • Pancreas Cancer (protocolSection.conditionsModule.conditions)
  • Liver Cancer (protocolSection.conditionsModule.conditions)
  • Neuroendocrine Tumors (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['EQUITY GI'], 'description': '1. Ensuring appropriate biomarker testing and evidence-based care: Biomarker testing can also help choose treatment. Additionally, a tumor board will be conducted periodically to provide treatment recommendations to the treating physician. Participant will receive standard-of-care treatment if they enroll in this study. Participant will not receive any experimental treatment.\n2. Assistance with clinical trial enrollment. The study team will help enroll in a clinical trial appropriate for the condition.\n3. Health literacy: The study team will provide information relevant to your diagnosis to enrich your understanding of your condition and treatment. Investigator will provide questionnaires to assess your understanding before and after you have been provided with educational/informational material appropriate for your diagnosis.', 'name': 'EQUITY GI', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.